Cargando…
WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient vo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259112/ https://www.ncbi.nlm.nih.gov/pubmed/37312945 http://dx.doi.org/10.1177/20552076231179849 |
_version_ | 1785057598630789120 |
---|---|
author | Zhu, Qingling Li, Ying Su, Yajun Huang, Liuhong Liu, Jiajia Lin, Weihua |
author_facet | Zhu, Qingling Li, Ying Su, Yajun Huang, Liuhong Liu, Jiajia Lin, Weihua |
author_sort | Zhu, Qingling |
collection | PubMed |
description | OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient volunteer assessments and quantitative scoring criteria. RESULTS: In the medical staff evaluation, both clinicians and nurses had a positive attitude towards the mobile platform, believing that the design of the mobile platform was clearly visualized and easy to operate. In family volunteers’ evaluations, the summary of β-testing results showed that 90–100% of parents had a positive attitude towards the WeChat-based mobile platform. Parents of the patients and doctors and nurses assessed the mobile platform by reviewing quantitative scoring standards developed by professional researchers. All scores were >16 (the average score was 18–19.3). Children treated with growth hormone therapy were included for compliance tracking for one year, and patient adherence was described in this study. CONCLUSION: The interaction based on the WeChat platform and the health education of the public have greatly increased the interaction between doctors and patients, and improved patient satisfaction and compliance. |
format | Online Article Text |
id | pubmed-10259112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-102591122023-06-13 WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study Zhu, Qingling Li, Ying Su, Yajun Huang, Liuhong Liu, Jiajia Lin, Weihua Digit Health Original Research OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient volunteer assessments and quantitative scoring criteria. RESULTS: In the medical staff evaluation, both clinicians and nurses had a positive attitude towards the mobile platform, believing that the design of the mobile platform was clearly visualized and easy to operate. In family volunteers’ evaluations, the summary of β-testing results showed that 90–100% of parents had a positive attitude towards the WeChat-based mobile platform. Parents of the patients and doctors and nurses assessed the mobile platform by reviewing quantitative scoring standards developed by professional researchers. All scores were >16 (the average score was 18–19.3). Children treated with growth hormone therapy were included for compliance tracking for one year, and patient adherence was described in this study. CONCLUSION: The interaction based on the WeChat platform and the health education of the public have greatly increased the interaction between doctors and patients, and improved patient satisfaction and compliance. SAGE Publications 2023-05-31 /pmc/articles/PMC10259112/ /pubmed/37312945 http://dx.doi.org/10.1177/20552076231179849 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Zhu, Qingling Li, Ying Su, Yajun Huang, Liuhong Liu, Jiajia Lin, Weihua WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title | WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title_full | WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title_fullStr | WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title_full_unstemmed | WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title_short | WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study |
title_sort | wechat-based mobile health management for short-stature children with long-term growth hormone therapy: a nonexperimental study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259112/ https://www.ncbi.nlm.nih.gov/pubmed/37312945 http://dx.doi.org/10.1177/20552076231179849 |
work_keys_str_mv | AT zhuqingling wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy AT liying wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy AT suyajun wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy AT huangliuhong wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy AT liujiajia wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy AT linweihua wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy |